Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Moodys
Express Scripts
McKinsey
Johnson and Johnson

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Details for Patent: 9,789,210

See Plans and Pricing

« Back to Dashboard

Which drugs does patent 9,789,210 protect, and when does it expire?

Patent 9,789,210 protects DEFINITY and is included in one NDA.

This patent has thirteen patent family members in thirteen countries.

Summary for Patent: 9,789,210
Title:Methods for making ultrasound contrast agents
Abstract: Provided herein are improved methods for preparing phospholipid formulations including phospholipid UCA formulations.
Inventor(s): Robinson; Simon P. (Stow, MA), Siegler; Robert W. (Chelmsford, MA), Nguyen; Nhung Tuyet (Westford, MA), Onthank; David C. (Groton, MA), Anklekar; Tarakeshwar Vishwanath (Billerica, MA), Van Kirk; Charles Chester (Beverly, MA)
Assignee: Lantheus Medical Imaging, Inc. (North Billerica, MA)
Application Number:15/461,469
Patent Claim Types:
see list of patent claims
Use; Formulation;

Drugs Protected by US Patent 9,789,210

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Lantheus Medcl DEFINITY perflutren INJECTABLE;INTRAVENOUS 021064-001 Jul 31, 2001 RX Yes Yes   Start Trial   Start Trial METHOD OF USING THE DRUG SUBSTANCE/DRUG PRODUCT FOR ULTRASOUND IMAGING   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,789,210

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2017291815   Start Trial
Brazil 112018074469   Start Trial
Canada 3025580   Start Trial
China 109562194   Start Trial
Eurasian Patent Organization 201892568   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Mallinckrodt
Moodys
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.